Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules
CHEST · 2023-10 · 164 (4) · 1028-1041
DOI: 10.1016/j.chest.2023.05.025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CHEST, 2023-10. Verfasst von Rafael Paez und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN. Hauptthemen laut MEDLINE: Multiple Pulmonary Nodules, Lung Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Comprehensive Cancer Network.
Abstract (Originalsprache)
Lung cancer is the leading cause of cancer-related deaths. Early detection and diagnosis are critical, as survival decreases with advanced stages. Approximately 1.6 million nodules are incidentally detected every year on chest CT scan images in the United States. This number of nodules identified is likely much larger after accounting for screening-detected nodules. Most of these nodules, whether incidentally or screening detected, are benign. Despite this, many patients undergo unnecessary invasive procedures to rule out cancer because our current stratification approaches are suboptimal, particularly for intermediate probability nodules. Thus, noninvasive strategies are urgently needed. Biomarkers have been developed to assist through the continuum of lung cancer care and include blood protein-based biomarkers, liquid biopsies, quantitative imaging analysis (radiomics), exhaled volatile organic compounds, and bronchial or nasal epithelium genomic classifiers, among others. Although many biomarkers have been developed, few have been integrated into clinical practice as they lack clinical utility studies showing improved patient-centered outcomes. Rapid technologic advances and large network collaborative efforts will continue to drive the discovery and validation of many novel biomarkers. Ultimately, however, randomized clinical utility studies showing improved patient outcomes will be required to bring biomarkers into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN.
- Department of Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC.
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
- Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN; Vanderbilt-Ingram Cancer Center, Nashville, TN.
- Department of Medicine, Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA.
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- National Comprehensive Cancer Network
- National Cancer Institute
Zitieren
APA
Paez, R., Kammer, M. N., Tanner, N. T., Shojaee, S., Heideman, B. E., Peikert, T., Balbach, M. L., Iams, W. T., Ning, B., Lenburg, M. E., Mallow, C., Yarmus, L., Fong, K. M., Deppen, S., Grogan, E. L., & Maldonado, F. (2023). Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules. CHEST, 164(4), 1028-1041. https://doi.org/10.1016/j.chest.2023.05.025
Vancouver
Paez R, Kammer MN, Tanner NT, Shojaee S, Heideman BE, Peikert T, et al. Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules. CHEST. 2023;164(4):1028-1041. doi:10.1016/j.chest.2023.05.025
BibTeX
@article{Paez2023,
author = {Paez, Rafael and Kammer, Michael N and Tanner, Nicole T and Shojaee, Samira and Heideman, Brent E and Peikert, Tobias and Balbach, Meridith L and Iams, Wade T and Ning, Boting and Lenburg, Marc E and Mallow, Christopher and Yarmus, Lonny and Fong, Kwun M and Deppen, Stephen and Grogan, Eric L and Maldonado, Fabien},
title = {Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules},
journal = {CHEST},
year = {2023},
volume = {164},
number = {4},
pages = {1028--1041},
doi = {10.1016/j.chest.2023.05.025}
}
EUVIMED